SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/04/14 Morgan Stanley 10-Q 9/30/14 122:46M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 4.01M 2: EX-10.1 Material Contract HTML 42K 3: EX-10.2 Material Contract HTML 40K 4: EX-12 Statement re: Computation of Ratios HTML 64K 5: EX-15 Letter re: Unaudited Interim Financial Information HTML 44K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 42K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 42K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 37K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 37K 83: R1 Document and Entity Information HTML 64K 63: R2 Consolidated Statements of Financial Condition HTML 172K 78: R3 Consolidated Statements of Financial Condition HTML 105K (Parenthetical) 87: R4 Consolidated Statements of Income HTML 175K 111: R5 Consolidated Statements of Comprehensive Income HTML 89K 66: R6 Consolidated Statements of Cash Flows HTML 177K 77: R7 Consolidated Statements of Changes in Total Equity HTML 75K 57: R8 Introduction and Basis of Presentation HTML 75K 46: R9 Significant Accounting Policies HTML 60K 113: R10 Wealth Management JV HTML 49K 89: R11 Fair Value Disclosures HTML 1.33M 88: R12 Available for Sale Securities HTML 254K 95: R13 Collateralized Transactions HTML 108K 96: R14 Variable Interest Entities and Securitization HTML 300K Activities 93: R15 Loans and Allowance for Loan Losses HTML 290K 97: R16 Long-Term Borrowings and Other Secured Financings HTML 58K 79: R17 Derivative Instruments and Hedging Activities HTML 595K 84: R18 Commitments, Guarantees and Contingencies HTML 176K 91: R19 Regulatory Requirements HTML 129K 121: R20 Total Equity HTML 154K 106: R21 Earnings Per Common Share HTML 107K 72: R22 Interest Income and Interest Expense HTML 75K 90: R23 Employee Benefit Plans HTML 55K 75: R24 Income Taxes HTML 55K 36: R25 Segment and Geographic Information HTML 232K 107: R26 Equity Method Investments HTML 53K 117: R27 Subsequent Events HTML 48K 51: R28 Significant Accounting Policies (Policies) HTML 63K 50: R29 Fair Value Disclosures (Tables) HTML 1.29M 55: R30 Available for Sale Securities (Tables) HTML 243K 56: R31 Collateralized Transactions (Tables) HTML 94K 58: R32 Variable Interest Entities and Securitization HTML 254K Activities (Tables) 24: R33 Loans and Allowance for Loan Losses (Tables) HTML 269K 104: R34 Long-Term Borrowings and Other Secured Financings HTML 52K (Tables) 70: R35 Derivative Instruments and Hedging Activities HTML 549K (Tables) 73: R36 Commitments, Guarantees and Contingencies (Tables) HTML 106K 41: R37 Regulatory Requirements (Tables) HTML 98K 120: R38 Total Equity (Tables) HTML 120K 16: R39 Earnings Per Common Share (Tables) HTML 105K 60: R40 Interest Income and Interest Expense (Tables) HTML 74K 110: R41 Employee Benefit Plans (Tables) HTML 52K 38: R42 Segment and Geographic Information (Tables) HTML 226K 49: R43 Introduction and Basis of Presentation (Details) HTML 51K 54: R44 Significant Accounting Policies (Details) HTML 40K 64: R45 Wealth Management JV (Details) HTML 51K 23: R46 Fair Value Disclosures (Assets and Liabilities HTML 271K Measured at Fair Value on a Recurring Basis) (Details) 45: R47 Fair Value Disclosures (Changes in Level 3 Assets HTML 257K and Liabilities Measured at Fair Value on a Recurring Basis) (Details) 18: R48 Fair Value Disclosures (Quantitative Information HTML 256K about and Sensitivity of Significant Unobservable Inputs Used in Recurring Level 3 Fair Value Measurements) (Details) 109: R49 Fair Value Disclosures (Fair Value of Investments HTML 86K that Calculate Net Asset Value) (Details) 37: R50 Fair Value Disclosures (Net Gains (Losses) Due to HTML 59K Changes in Fair Value for Items Measured at Fair Value Pursuant to the Fair Value Option Election) (Details) 105: R51 Fair Value Disclosures (Short-term and Long-term HTML 43K Borrowings) (Details) 42: R52 Fair Value Disclosures (Gains (Losses) Due to HTML 39K Changes in Instrument Specific Credit Risk) (Details) 61: R53 Fair Value Disclosures (Net Difference between HTML 48K Contractual Principal Amount and Fair Value) (Details) 17: R54 Fair Value Disclosures (Assets Measured at Fair HTML 104K Value on a Nonrecurring Basis) (Details) 21: R55 Fair Value Disclosures (Financial Instruments Not HTML 124K Carried at FV) (Details) 53: R56 Available for Sale Securities (Schedule of HTML 79K Available for Sale Securities) (Details) 28: R57 Available for Sale Securities (Schedule of HTML 88K Available for Sale Securities in an Unrealized Loss Position) (Details) 114: R58 Available for Sale Securities (Schedule of HTML 115K Amortized Cost and Fair Value of Available for Sale Debt Securities by Contractual Date) (Details) 68: R59 Available for Sale Securities (Schedule of HTML 41K Proceeds of Sale of Securities Available for Sale) (Details) 94: R60 Collateralized Transactions (Narrative) (Details) HTML 44K 44: R61 Collateralized Transactions (Balance Sheet HTML 106K Offsetting) (Details) 47: R62 Collateralized Transactions (Financial Instruments HTML 43K Owned That Have Been Loaned Or Pledged To Counterparties) (Details) 102: R63 Collateralized Transactions (Cash And Securities HTML 43K Deposited With Clearing Organizations Or Segregated Under Federal And Other Regulations Or Requirements) (Details) 98: R64 Variable Interest Entities and Securitization HTML 57K Activities (Narrative) (Details) 71: R65 Variable Interest Entities and Securitization HTML 45K Activities (Consolidated VIEs) (Details) 100: R66 Variable Interest Entities and Securitization HTML 95K Activities (Non-Consolidated VIEs) (Details) 43: R67 Variable Interest Entities and Securitization HTML 75K Activities (Transfers of Assets with Continuing Involvement 1) (Details) 76: R68 Variable Interest Entities and Securitization HTML 67K Activities (Transfers of Assets with Continuing Involvement 2) (Details) 116: R69 Variable Interest Entities and Securitization HTML 44K Activities (Failed Sales) (Details) 20: R70 Variable Interest Entities and Securitization HTML 54K Activities (Mortgage Servicing Activities) (Details) 35: R71 Loans and Allowance for Loan Losses (Outstanding HTML 110K Loans and Credit Quality) (Details) 62: R72 Loans and Allowance for Loan Losses (Impaired HTML 66K Loans) (Details) 26: R73 Loans and Allowance for Loan Losses (Loans and HTML 126K Lending-related Commitments) (Details) 119: R74 Loans and Allowance for Loan Losses (Employee HTML 45K Loans) (Details) 39: R75 Long-Term Borrowings and Other Secured Financings HTML 42K (Narratives) (Details) 29: R76 Long-Term Borrowings and Other Secured Financings HTML 50K (Long-term Borrowings) (Details) 34: R77 Long-Term Borrowings and Other Secured Financings HTML 47K (Other Secured Financings) (Details) 22: R78 Derivative Instruments and Hedging Activities HTML 69K (Other Disclosures) (Details) 25: R79 Derivative Instruments and Hedging Activities HTML 104K (Components of Derivative Products) (Details) 85: R80 Derivative Instruments and Hedging Activities HTML 66K (Fair Value of OTC Derivatives in a Gain Position) (Details) 32: R81 Derivative Instruments and Hedging Activities HTML 210K (Fair Value of Derivative Instruments Designated and Not Designated as Accounting Hedges by Type of Derivative Contract on a Gross Basis) (Details) 115: R82 Derivative Instruments and Hedging Activities HTML 61K (Gains or Losses on Derivative Instruments, Related Hedge Items and Hedge Ineffectiveness) (Details) 59: R83 Derivative Instruments and Hedging Activities HTML 129K (Notional and Fair Value of Protection Sold and Purchased through Credit Default Swaps) (Details) 92: R84 Commitments, Guarantees and Contingencies HTML 79K (Narrative) (Details) 99: R85 Commitments, Guarantees and Contingencies HTML 75K (Commitments) (Details) 31: R86 Commitments, Guarantees and Contingencies HTML 87K (Obligations under Guarantee Arrangements) (Details) 33: R87 Regulatory Requirements (Narrative) (Details) HTML 49K 112: R88 Regulatory Requirements (Capital Measures) HTML 77K (Details) 27: R89 Regulatory Requirements (Significant U.S. Bank HTML 72K Operating Subsidiaries' Capital) (Details) 86: R90 Total Equity (Narrative) (Details) HTML 67K 82: R91 Total Equity (Preferred Stock) (Details) HTML 68K 103: R92 Total Equity (Components of Accumulated Other HTML 57K Comprehensive Income (Loss)) (Details) 81: R93 Earnings Per Common Share (Calculation of Basic HTML 117K and Diluted EPS) (Details) 67: R94 Earnings Per Common Share (Antidilutive Securities HTML 40K Excluded from the Computation of Diluted EPS) (Details) 108: R95 Interest Income and Interest Expense (Details) HTML 79K 65: R96 Employee Benefit Plans (Net Periodic Benefit HTML 57K Expense) (Details) 40: R97 Income Taxes (Reconciliation of the Provision for HTML 54K (Benefit from) Income Taxes and the U.S. Federal Statutory Income Tax Rate) (Details) 74: R98 Income Taxes (Investments in Qualified Affordable HTML 44K Housing Projects) (Details) 69: R99 Segment and Geographic Information (Selected HTML 141K Financial Information by Segments) (Details) 52: R100 Segment and Geographic Information (Assets by HTML 43K Segments) (Details) 122: R101 Segment and Geographic Information (Net Revenues HTML 42K by Geographic Area) (Details) 101: R102 Equity Method Investments (Narratives) (Details) HTML 57K 80: R103 Subsequent Events (Details) HTML 56K 118: XML IDEA XML File -- Filing Summary XML 196K 19: EXCEL IDEA Workbook of Financial Reports XLSX 651K 48: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 8.10M 10: EX-101.INS XBRL Instance -- ms-20140930 XML 16.06M 12: EX-101.CAL XBRL Calculations -- ms-20140930_cal XML 508K 13: EX-101.DEF XBRL Definitions -- ms-20140930_def XML 2.97M 14: EX-101.LAB XBRL Labels -- ms-20140930_lab XML 5.47M 15: EX-101.PRE XBRL Presentations -- ms-20140930_pre XML 3.77M 11: EX-101.SCH XBRL Schema -- ms-20140930 XSD 560K 30: ZIP XBRL Zipped Folder -- 0001193125-14-396227-xbrl Zip 769K
EX-32.1 |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Morgan Stanley (the “Company”) on Form 10-Q for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James P. Gorman, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ JAMES P. GORMAN |
James P. Gorman |
Chairman and Chief Executive Officer |
Dated: November 4, 2014
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/4/14 | 4, 424B2, FWP | ||
For Period end: | 9/30/14 | 13F-HR, 13F-HR/A, 424B2, FWP | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/24 Morgan Stanley 10-K 12/31/23 224:45M 2/24/23 Morgan Stanley 10-K 12/31/22 227:50M 2/24/22 Morgan Stanley 10-K 12/31/21 225:51M 2/26/21 Morgan Stanley 10-K 12/31/20 225:50M |